| Pedro Jose Briceno, MD | |
|
1950 Arlington St Ste 101, Sarasota, FL 34239 | |
| (941) 917-3400 | |
| (941) 917-4300 |
| Full Name | Pedro Jose Briceno |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 24 Years |
| Location | 1950 Arlington St Ste 101, Sarasota, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275748659 | NPI | - | NPPES |
| 001579800 | Medicaid | FL | |
| 33181 | Other | FL | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | MD427760 (Pennsylvania) | Secondary |
| 208600000X | Surgery | ME105330 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sarasota Memorial Hospital | Sarasota, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Smh Physician Services Inc | 1355240177 | 592 |
News Archive
Prophylactic cranial irradiation after chemotherapy significantly reduces the risk of brain metastasis and doubles one-year survival in small-cell lung cancer (SCLC), according to the results of the multicenter phase III randomized EORTC trial 08993-22993, published in the New England Journal of Medicine.
Harvard Bioscience, Inc., a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research and regenerative medicine, announces that its Harvard Apparatus / Hugo Sachs Elektronik business collaborated with Dr. Harald Ott and Massachusetts General Hospital (MGH) to design and manufacture a novel bioreactor that was used to grow a functional lung. The lung was subsequently transplanted into a rat.
The four-year REDUCE (REduction by DUtasteride of prostate Cancer Events) clinical study evaluated prostate cancer risk reduction in men taking dutasteride, a 5-alpha-reductase inhibitor (5ARI) typically used to treat enlarged prostate.
As cold winter weather approaches, millions of people look for remedies to avoid the flu. Yet influenza outbreaks equally affect those living in warm, tropical regions where there is no direct link to seasonal temperature changes.
› Verified 7 days ago
| Entity Name | Smh Physician Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346295292 PECOS PAC ID: 1355240177 Enrollment ID: O20031231000211 |
News Archive
Prophylactic cranial irradiation after chemotherapy significantly reduces the risk of brain metastasis and doubles one-year survival in small-cell lung cancer (SCLC), according to the results of the multicenter phase III randomized EORTC trial 08993-22993, published in the New England Journal of Medicine.
Harvard Bioscience, Inc., a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research and regenerative medicine, announces that its Harvard Apparatus / Hugo Sachs Elektronik business collaborated with Dr. Harald Ott and Massachusetts General Hospital (MGH) to design and manufacture a novel bioreactor that was used to grow a functional lung. The lung was subsequently transplanted into a rat.
The four-year REDUCE (REduction by DUtasteride of prostate Cancer Events) clinical study evaluated prostate cancer risk reduction in men taking dutasteride, a 5-alpha-reductase inhibitor (5ARI) typically used to treat enlarged prostate.
As cold winter weather approaches, millions of people look for remedies to avoid the flu. Yet influenza outbreaks equally affect those living in warm, tropical regions where there is no direct link to seasonal temperature changes.
› Verified 7 days ago
| Entity Name | Imminent Surgical Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316338551 PECOS PAC ID: 1456663517 Enrollment ID: O20150701001986 |
News Archive
Prophylactic cranial irradiation after chemotherapy significantly reduces the risk of brain metastasis and doubles one-year survival in small-cell lung cancer (SCLC), according to the results of the multicenter phase III randomized EORTC trial 08993-22993, published in the New England Journal of Medicine.
Harvard Bioscience, Inc., a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research and regenerative medicine, announces that its Harvard Apparatus / Hugo Sachs Elektronik business collaborated with Dr. Harald Ott and Massachusetts General Hospital (MGH) to design and manufacture a novel bioreactor that was used to grow a functional lung. The lung was subsequently transplanted into a rat.
The four-year REDUCE (REduction by DUtasteride of prostate Cancer Events) clinical study evaluated prostate cancer risk reduction in men taking dutasteride, a 5-alpha-reductase inhibitor (5ARI) typically used to treat enlarged prostate.
As cold winter weather approaches, millions of people look for remedies to avoid the flu. Yet influenza outbreaks equally affect those living in warm, tropical regions where there is no direct link to seasonal temperature changes.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Pedro Jose Briceno, MD Po Box 863407, Orlando, FL 32886-3407 Ph: (941) 917-2600 | Pedro Jose Briceno, MD 1950 Arlington St Ste 101, Sarasota, FL 34239 Ph: (941) 917-3400 |
News Archive
Prophylactic cranial irradiation after chemotherapy significantly reduces the risk of brain metastasis and doubles one-year survival in small-cell lung cancer (SCLC), according to the results of the multicenter phase III randomized EORTC trial 08993-22993, published in the New England Journal of Medicine.
Harvard Bioscience, Inc., a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research and regenerative medicine, announces that its Harvard Apparatus / Hugo Sachs Elektronik business collaborated with Dr. Harald Ott and Massachusetts General Hospital (MGH) to design and manufacture a novel bioreactor that was used to grow a functional lung. The lung was subsequently transplanted into a rat.
The four-year REDUCE (REduction by DUtasteride of prostate Cancer Events) clinical study evaluated prostate cancer risk reduction in men taking dutasteride, a 5-alpha-reductase inhibitor (5ARI) typically used to treat enlarged prostate.
As cold winter weather approaches, millions of people look for remedies to avoid the flu. Yet influenza outbreaks equally affect those living in warm, tropical regions where there is no direct link to seasonal temperature changes.
› Verified 7 days ago
Dr. Alfredo Cesar Cordova, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1921 Waldemere St, Sarasota, FL 34239 Phone: 941-917-1579 Fax: 941-917-4340 | |
Dr. Russell Warren Novak, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1950 Arlington St, Suite 310, Sarasota, FL 34239 Phone: 941-917-6300 Fax: 941-917-6306 | |
Ryan Stark Suplee, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 3333 Cattlemen Rd Ste 206, Sarasota, FL 34232 Phone: 941-341-0042 | |
Suzanne Steelman, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 1900 Brother Geenen Way, Sarasota, FL 34236 Phone: 941-556-3220 Fax: 941-955-8214 | |
Dr. Thomas F Kelly Jr., M.D., P.A. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1540 S Tamiami Trl, Suite 303, Sarasota, FL 34239 Phone: 941-917-8791 Fax: 941-917-8793 | |
Scott Jeffrey Engel, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 2255 S Tamiami Trl, Sarasota, FL 34239 Phone: 941-366-8897 Fax: 941-366-0518 | |
Issam D Soussou, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 3333 Cattlemen Rd, Suite 206, Sarasota, FL 34232 Phone: 941-341-0042 Fax: 941-342-3432 |